Search research articles
Contact Us
Filters
Showing results (351-360 of 371) with videos related to
Page
of 38
Sort By:
Cell Reports. Medicine
|
December 31, 2025
Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndrome
Xingxian Liu, Jiaqi Li, Yajing Zhang, et al.
Oncoimmunology
|
October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
Hanren Dai, Wenying Zhang, Xiaolei Li, et al.
Scientific Reports
|
April 16, 2014
JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
Xinbing Sui, Na Kong, Xian Wang, et al.
Journal of Medicinal Chemistry
|
August 19, 2024
Rational Design of a Novel 6<i>H</i>-Benzo[<i>c</i>]chromen Series as Selective PI3Kα Inhibitors
Xue Shi, Heng Feng, Haigang Tian, et al.
Cancer Cell
|
September 20, 2024
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation
Yang Gao, Jianan Li, Wenfeng Cheng, et al.
Cellular & Molecular Immunology
|
August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
Zhenguang Wang, Na Li, Kaichao Feng, et al.
Therapeutic Advances in Medical Oncology
|
June 16, 2020
Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL
Changlin Yu, Bo Cai, Yao Wang, et al.
Frontiers in Immunology
|
October 17, 2022
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
Jiawei Shou, Fan Mo, Shanshan Zhang, et al.
BMC Cancer
|
April 10, 2024
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors
Ye Guo, Zishu Wang, Huan Zhou, et al.
International Journal of Cancer
|
November 7, 2019
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment
Weiting Ge, Hanguang Hu, Wen Cai, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 371) with videos related to
Sort By:
Page
of 38
Cell Reports. Medicine
|
December 31, 2025
Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndrome
Xingxian Liu, Jiaqi Li, Yajing Zhang, et al.
Oncoimmunology
|
October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
Hanren Dai, Wenying Zhang, Xiaolei Li, et al.
Scientific Reports
|
April 16, 2014
JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
Xinbing Sui, Na Kong, Xian Wang, et al.
Journal of Medicinal Chemistry
|
August 19, 2024
Rational Design of a Novel 6<i>H</i>-Benzo[<i>c</i>]chromen Series as Selective PI3Kα Inhibitors
Xue Shi, Heng Feng, Haigang Tian, et al.
Cancer Cell
|
September 20, 2024
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation
Yang Gao, Jianan Li, Wenfeng Cheng, et al.
Cellular & Molecular Immunology
|
August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
Zhenguang Wang, Na Li, Kaichao Feng, et al.
Therapeutic Advances in Medical Oncology
|
June 16, 2020
Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL
Changlin Yu, Bo Cai, Yao Wang, et al.
Frontiers in Immunology
|
October 17, 2022
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
Jiawei Shou, Fan Mo, Shanshan Zhang, et al.
BMC Cancer
|
April 10, 2024
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors
Ye Guo, Zishu Wang, Huan Zhou, et al.
International Journal of Cancer
|
November 7, 2019
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment
Weiting Ge, Hanguang Hu, Wen Cai, et al.
Page
of 38